Autoantibodies to p53 have been reported in patients with early stage ovarian or colorectal cancers[13], and a panel of serum antibodies can detect non-small cell lung cancer (NSCLC) 5 years prior to autoradiograph detection[14]. Here, TP53 is linked to non-small cell lung carcinoma.